LOGIN
ISAKOS2017: Efficacy of IORA vs. IV vancomycin in revision total knee arthroplasty
July 2017
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
20 patients scheduled for revision total knee arthroplasty were randomized to either intraosseous regional administration or intravenous administration of prophylactic vancomycin. Intraoperative subcutaneous fat and femoral bone samples were taken. Results demonstrated significantly greater concentration of vancomycin in samples in the IORA group compared to the IV group.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.